GENE ONLINE|News &
Opinion
Blog

2025-11-28|

Study Finds Link Between Infant Antibiotic Use and Increased Risk of Childhood Overweight

by GOAI
Share To

A recent study has identified a potential link between antibiotic use in infancy and an increased risk of childhood overweight. Researchers examined the impact of antibiotics on the gut microbiome, a complex network of microorganisms in the intestines that influences digestion, immune response, and energy metabolism. The findings suggest that early exposure to antibiotics may disrupt this delicate ecosystem, potentially affecting metabolic health and weight regulation later in life.

The research highlights the critical role of gut flora in physiological processes and underscores concerns about how antibiotics might alter its composition during crucial developmental stages. Scientists have increasingly focused on the human microbiome’s connection to metabolic health, with this study adding evidence to the growing body of work suggesting long-term effects from early-life interventions. Further investigation is needed to fully understand these implications and their potential influence on public health guidelines regarding antibiotic use in infants.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: November 29, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
LATEST
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
Scroll to Top